BencoCaine Topical Anesthetic

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: BencoCaine Topical Anesthetic
Generic name: BENZOCAINE
Manufacturer: Benco Dental
Product type: HUMAN OTC DRUG
SPL set ID: 05e31aaa-a932-f48b-e063-6394a90af32e
SPL ID: 2b3a8cb2-17a2-ed01-e063-6394a90ae069
Version: 2
Effective date: 2025-01-08
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:56:27

Harmonized routes table
Harmonized routes
DENTAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M022	openfda.application_number
brand name		BencoCaine Topical Anesthetic	openfda.brand_name
generic name		BENZOCAINE	openfda.generic_name
manufacturer name		Benco Dental	openfda.manufacturer_name
ndc	package	66975-341-30	openfda.package_ndc
ndc	product	66975-341	openfda.product_ndc
ndc11	package	66975034130	derived:openfda.package_ndc
rxcui		238910	openfda.rxcui
rxcui		1541816	openfda.rxcui
spl id		2b3a8cb2-17a2-ed01-e063-6394a90ae069	id
spl set id		05e31aaa-a932-f48b-e063-6394a90af32e	set_id
unii		U3RSY48JW5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Warnings Methemoglolllnemla warning: Use of this product may cause methemoglobinemia, a seriouscondit~n that must be treated promptly because tt reduces the amount of oxygen carried in the blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: • pale, gray or blue colored skin (cyanosis) •headache rapid heart rate • shortness of breath • dizziness or lightheadedness • fatigue or lack of energy

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.